CHD7 and Runx1 interaction provides a braking mechanism for hematopoietic differentiation

Author:

Hsu Jingmei,Huang Hsuan-TingORCID,Lee Chung-TsaiORCID,Choudhuri Avik,Wilson Nicola K.ORCID,Abraham Brian J.,Moignard Victoria,Kucinski Iwo,Yu Shuqian,Hyde R. Katherine,Tober Joanna,Cai XiongweiORCID,Li YanORCID,Guo YalinORCID,Yang Song,Superdock Michael,Trompouki EiriniORCID,Calero-Nieto Fernando J.,Ghamari Alireza,Jiang Jing,Gao Peng,Gao Long,Nguyen Vy,Robertson Anne L.,Durand Ellen M.,Kathrein Katie L.,Aifantis Iannis,Gerber Scott A.,Tong Wei,Tan KaiORCID,Cantor Alan B.,Zhou YiORCID,Liu P. Paul,Young Richard A.,Göttgens BertholdORCID,Speck Nancy A.ORCID,Zon Leonard I.ORCID

Abstract

Hematopoietic stem and progenitor cell (HSPC) formation and lineage differentiation involve gene expression programs orchestrated by transcription factors and epigenetic regulators. Genetic disruption of the chromatin remodeler chromodomain-helicase-DNA-binding protein 7 (CHD7) expanded phenotypic HSPCs, erythroid, and myeloid lineages in zebrafish and mouse embryos. CHD7 acts to suppress hematopoietic differentiation. Binding motifs for RUNX and other hematopoietic transcription factors are enriched at sites occupied by CHD7, and decreased RUNX1 occupancy correlated with loss of CHD7 localization. CHD7 physically interacts with RUNX1 and suppresses RUNX1-induced expansion of HSPCs during development through modulation of RUNX1 activity. Consequently, the RUNX1:CHD7 axis provides proper timing and function of HSPCs as they emerge during hematopoietic development or mature in adults, representing a distinct and evolutionarily conserved control mechanism to ensure accurate hematopoietic lineage differentiation.

Funder

HHS | NIH | National Heart, Lung, and Blood Institute

HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases

HHS | NIH | National Human Genome Research Institute

HHS | NIH | National Cancer Institute

Bloodwise

Leukemia and Lymphoma Society

Cancer Research UK

Wellcome Trust and MRC to the Wellcome Trust and MRC Cambridge Stem Cell Institute

New York State Stem Cell Science

Howard Hughes Medical Institute

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3